instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
What was the administration route of drug 'CILASTATIN SODIUM\IMIPENEM'? | The first case of Janibacter hoylei bacteremia in an adult.
The Janibacter species are Gram positive, coryneform bacteria that belong to the Actinobacteria phylum and have been linked to bacteremia in immunocompromised children. We present the first documented adult case of Janibacter hoylei bacteremia. The patient was... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 34877256 | 20,709,296 | 2021 |
What was the administration route of drug 'LINEZOLID'? | The first case of Janibacter hoylei bacteremia in an adult.
The Janibacter species are Gram positive, coryneform bacteria that belong to the Actinobacteria phylum and have been linked to bacteremia in immunocompromised children. We present the first documented adult case of Janibacter hoylei bacteremia. The patient was... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 34877256 | 20,709,296 | 2021 |
What was the administration route of drug 'VANCOMYCIN'? | The first case of Janibacter hoylei bacteremia in an adult.
The Janibacter species are Gram positive, coryneform bacteria that belong to the Actinobacteria phylum and have been linked to bacteremia in immunocompromised children. We present the first documented adult case of Janibacter hoylei bacteremia. The patient was... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 34877256 | 20,709,296 | 2021 |
What was the dosage of drug 'FLUDARABINE PHOSPHATE'? | The first case of Janibacter hoylei bacteremia in an adult.
The Janibacter species are Gram positive, coryneform bacteria that belong to the Actinobacteria phylum and have been linked to bacteremia in immunocompromised children. We present the first documented adult case of Janibacter hoylei bacteremia. The patient was... | UNK UNK, UNKNOWN FREQ. | DrugDosageText | CC BY-NC-ND | 34877256 | 20,699,931 | 2021 |
What was the dosage of drug 'MELPHALAN'? | The first case of Janibacter hoylei bacteremia in an adult.
The Janibacter species are Gram positive, coryneform bacteria that belong to the Actinobacteria phylum and have been linked to bacteremia in immunocompromised children. We present the first documented adult case of Janibacter hoylei bacteremia. The patient was... | UNK UNK, UNKNOWN FREQ. | DrugDosageText | CC BY-NC-ND | 34877256 | 20,699,931 | 2021 |
What was the dosage of drug 'METHOTREXATE'? | The first case of Janibacter hoylei bacteremia in an adult.
The Janibacter species are Gram positive, coryneform bacteria that belong to the Actinobacteria phylum and have been linked to bacteremia in immunocompromised children. We present the first documented adult case of Janibacter hoylei bacteremia. The patient was... | UNK UNK, UNKNOWN FREQ. | DrugDosageText | CC BY-NC-ND | 34877256 | 20,699,931 | 2021 |
What was the dosage of drug 'TACROLIMUS'? | The first case of Janibacter hoylei bacteremia in an adult.
The Janibacter species are Gram positive, coryneform bacteria that belong to the Actinobacteria phylum and have been linked to bacteremia in immunocompromised children. We present the first documented adult case of Janibacter hoylei bacteremia. The patient was... | UNK UNK, UNKNOWN FREQ. | DrugDosageText | CC BY-NC-ND | 34877256 | 20,699,931 | 2021 |
What was the outcome of reaction 'Acute kidney injury'? | The first case of Janibacter hoylei bacteremia in an adult.
The Janibacter species are Gram positive, coryneform bacteria that belong to the Actinobacteria phylum and have been linked to bacteremia in immunocompromised children. We present the first documented adult case of Janibacter hoylei bacteremia. The patient was... | Fatal | ReactionOutcome | CC BY-NC-ND | 34877256 | 20,722,578 | 2021 |
What was the outcome of reaction 'Bone marrow failure'? | The first case of Janibacter hoylei bacteremia in an adult.
The Janibacter species are Gram positive, coryneform bacteria that belong to the Actinobacteria phylum and have been linked to bacteremia in immunocompromised children. We present the first documented adult case of Janibacter hoylei bacteremia. The patient was... | Fatal | ReactionOutcome | CC BY-NC-ND | 34877256 | 20,722,578 | 2021 |
What was the outcome of reaction 'Diarrhoea'? | The first case of Janibacter hoylei bacteremia in an adult.
The Janibacter species are Gram positive, coryneform bacteria that belong to the Actinobacteria phylum and have been linked to bacteremia in immunocompromised children. We present the first documented adult case of Janibacter hoylei bacteremia. The patient was... | Fatal | ReactionOutcome | CC BY-NC-ND | 34877256 | 20,722,578 | 2021 |
What was the outcome of reaction 'Hypertransaminasaemia'? | The first case of Janibacter hoylei bacteremia in an adult.
The Janibacter species are Gram positive, coryneform bacteria that belong to the Actinobacteria phylum and have been linked to bacteremia in immunocompromised children. We present the first documented adult case of Janibacter hoylei bacteremia. The patient was... | Fatal | ReactionOutcome | CC BY-NC-ND | 34877256 | 20,722,578 | 2021 |
What was the outcome of reaction 'Klebsiella bacteraemia'? | The first case of Janibacter hoylei bacteremia in an adult.
The Janibacter species are Gram positive, coryneform bacteria that belong to the Actinobacteria phylum and have been linked to bacteremia in immunocompromised children. We present the first documented adult case of Janibacter hoylei bacteremia. The patient was... | Fatal | ReactionOutcome | CC BY-NC-ND | 34877256 | 20,722,578 | 2021 |
What was the outcome of reaction 'Metabolic encephalopathy'? | The first case of Janibacter hoylei bacteremia in an adult.
The Janibacter species are Gram positive, coryneform bacteria that belong to the Actinobacteria phylum and have been linked to bacteremia in immunocompromised children. We present the first documented adult case of Janibacter hoylei bacteremia. The patient was... | Fatal | ReactionOutcome | CC BY-NC-ND | 34877256 | 20,722,578 | 2021 |
What was the outcome of reaction 'Mouth haemorrhage'? | The first case of Janibacter hoylei bacteremia in an adult.
The Janibacter species are Gram positive, coryneform bacteria that belong to the Actinobacteria phylum and have been linked to bacteremia in immunocompromised children. We present the first documented adult case of Janibacter hoylei bacteremia. The patient was... | Fatal | ReactionOutcome | CC BY-NC-ND | 34877256 | 20,722,578 | 2021 |
What was the outcome of reaction 'Sepsis'? | The first case of Janibacter hoylei bacteremia in an adult.
The Janibacter species are Gram positive, coryneform bacteria that belong to the Actinobacteria phylum and have been linked to bacteremia in immunocompromised children. We present the first documented adult case of Janibacter hoylei bacteremia. The patient was... | Fatal | ReactionOutcome | CC BY-NC-ND | 34877256 | 20,722,578 | 2021 |
What was the outcome of reaction 'Stomatitis'? | The first case of Janibacter hoylei bacteremia in an adult.
The Janibacter species are Gram positive, coryneform bacteria that belong to the Actinobacteria phylum and have been linked to bacteremia in immunocompromised children. We present the first documented adult case of Janibacter hoylei bacteremia. The patient was... | Fatal | ReactionOutcome | CC BY-NC-ND | 34877256 | 20,722,578 | 2021 |
What was the outcome of reaction 'Transplant failure'? | The first case of Janibacter hoylei bacteremia in an adult.
The Janibacter species are Gram positive, coryneform bacteria that belong to the Actinobacteria phylum and have been linked to bacteremia in immunocompromised children. We present the first documented adult case of Janibacter hoylei bacteremia. The patient was... | Fatal | ReactionOutcome | CC BY-NC-ND | 34877256 | 20,722,578 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Diabetic ketoacidosis'. | Acute esophageal necrosis as a complication of diabetic ketoacidosis: A case report.
BACKGROUND
Acute esophageal necrosis (AEN) is a rare condition that has been associated with low volume states, microvascular disease, gastrointestinal (GI) mucosal damage, and impaired GI motility. It has been linked in case reports w... | DULOXETINE, EZETIMIBE, METFORMIN HYDROCHLORIDE, PRAVASTATIN, RAMIPRIL, SEMAGLUTIDE | DrugsGivenReaction | CC BY-NC | 34877292 | 20,168,077 | 2021-11-06 |
What is the weight of the patient? | Acute esophageal necrosis as a complication of diabetic ketoacidosis: A case report.
BACKGROUND
Acute esophageal necrosis (AEN) is a rare condition that has been associated with low volume states, microvascular disease, gastrointestinal (GI) mucosal damage, and impaired GI motility. It has been linked in case reports w... | 94 kg. | Weight | CC BY-NC | 34877292 | 20,168,077 | 2021-11-06 |
What was the outcome of reaction 'Diabetic ketoacidosis'? | Acute esophageal necrosis as a complication of diabetic ketoacidosis: A case report.
BACKGROUND
Acute esophageal necrosis (AEN) is a rare condition that has been associated with low volume states, microvascular disease, gastrointestinal (GI) mucosal damage, and impaired GI motility. It has been linked in case reports w... | Recovered | ReactionOutcome | CC BY-NC | 34877292 | 20,168,077 | 2021-11-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cerebral infarction'. | T-cell lymphoblastic lymphoma with extensive thrombi and cardiac thrombosis: A case report and review of literature.
BACKGROUND
T-lymphoblastic lymphoma (T-LBL), a neoplasm of immature T-cell precursors or lymphoblasts, is a clinically aggressive disease. In general, patients with T-LBL have a poor prognosis and often ... | CYCLOPHOSPHAMIDE, DEXAMETHASONE, DOXORUBICIN, PEGASPARGASE, VINDESINE | DrugsGivenReaction | CC BY-NC | 34877297 | 20,232,087 | 2021-11-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Haemorrhage'. | T-cell lymphoblastic lymphoma with extensive thrombi and cardiac thrombosis: A case report and review of literature.
BACKGROUND
T-lymphoblastic lymphoma (T-LBL), a neoplasm of immature T-cell precursors or lymphoblasts, is a clinically aggressive disease. In general, patients with T-LBL have a poor prognosis and often ... | CYCLOPHOSPHAMIDE, DEXAMETHASONE, DOXORUBICIN, PEGASPARGASE, VINDESINE | DrugsGivenReaction | CC BY-NC | 34877297 | 20,232,087 | 2021-11-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hemiplegia'. | T-cell lymphoblastic lymphoma with extensive thrombi and cardiac thrombosis: A case report and review of literature.
BACKGROUND
T-lymphoblastic lymphoma (T-LBL), a neoplasm of immature T-cell precursors or lymphoblasts, is a clinically aggressive disease. In general, patients with T-LBL have a poor prognosis and often ... | CYCLOPHOSPHAMIDE, DEXAMETHASONE, DOXORUBICIN, PEGASPARGASE, VINDESINE | DrugsGivenReaction | CC BY-NC | 34877297 | 20,232,087 | 2021-11-06 |
What was the outcome of reaction 'Cerebral infarction'? | T-cell lymphoblastic lymphoma with extensive thrombi and cardiac thrombosis: A case report and review of literature.
BACKGROUND
T-lymphoblastic lymphoma (T-LBL), a neoplasm of immature T-cell precursors or lymphoblasts, is a clinically aggressive disease. In general, patients with T-LBL have a poor prognosis and often ... | Recovered | ReactionOutcome | CC BY-NC | 34877297 | 20,232,087 | 2021-11-06 |
What was the outcome of reaction 'Haemorrhage'? | T-cell lymphoblastic lymphoma with extensive thrombi and cardiac thrombosis: A case report and review of literature.
BACKGROUND
T-lymphoblastic lymphoma (T-LBL), a neoplasm of immature T-cell precursors or lymphoblasts, is a clinically aggressive disease. In general, patients with T-LBL have a poor prognosis and often ... | Recovered | ReactionOutcome | CC BY-NC | 34877297 | 20,232,087 | 2021-11-06 |
What was the outcome of reaction 'Hemiplegia'? | T-cell lymphoblastic lymphoma with extensive thrombi and cardiac thrombosis: A case report and review of literature.
BACKGROUND
T-lymphoblastic lymphoma (T-LBL), a neoplasm of immature T-cell precursors or lymphoblasts, is a clinically aggressive disease. In general, patients with T-LBL have a poor prognosis and often ... | Recovered | ReactionOutcome | CC BY-NC | 34877297 | 20,232,087 | 2021-11-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective for unapproved indication'. | Concurrent tuberculous transverse myelitis and asymptomatic neurosyphilis: A case report.
BACKGROUND
Tuberculous myelitis is a rare manifestation of tuberculosis (TB) that is usually caused by hematogenous spread of Mycobacterium tuberculosis (MTB). Neurosyphilis is a neurological disease that occurs when Treponema pal... | CEFTRIAXONE, DEXAMETHASONE | DrugsGivenReaction | CC BY-NC | 34877302 | 20,216,650 | 2021-11-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Concurrent tuberculous transverse myelitis and asymptomatic neurosyphilis: A case report.
BACKGROUND
Tuberculous myelitis is a rare manifestation of tuberculosis (TB) that is usually caused by hematogenous spread of Mycobacterium tuberculosis (MTB). Neurosyphilis is a neurological disease that occurs when Treponema pal... | CEFTRIAXONE, DEXAMETHASONE | DrugsGivenReaction | CC BY-NC | 34877302 | 20,216,650 | 2021-11-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Asthenia'. | Metachronous squamous cell carcinoma of pancreas and stomach in an elderly female patient: A case report.
BACKGROUND
Squamous cell carcinoma (SCC) in pancreas and stomach is a rare histologic subtype with aggressive behavior, poor prognosis, and no standardized therapy. Pancreatic SCC or gastric SCC has been previously... | CAPECITABINE, OXALIPLATIN | DrugsGivenReaction | CC BY-NC | 34877306 | 20,160,424 | 2021-11-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease progression'. | Metachronous squamous cell carcinoma of pancreas and stomach in an elderly female patient: A case report.
BACKGROUND
Squamous cell carcinoma (SCC) in pancreas and stomach is a rare histologic subtype with aggressive behavior, poor prognosis, and no standardized therapy. Pancreatic SCC or gastric SCC has been previously... | CAPECITABINE, OXALIPLATIN | DrugsGivenReaction | CC BY-NC | 34877306 | 20,160,424 | 2021-11-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Metachronous squamous cell carcinoma of pancreas and stomach in an elderly female patient: A case report.
BACKGROUND
Squamous cell carcinoma (SCC) in pancreas and stomach is a rare histologic subtype with aggressive behavior, poor prognosis, and no standardized therapy. Pancreatic SCC or gastric SCC has been previously... | CAPECITABINE, OXALIPLATIN | DrugsGivenReaction | CC BY-NC | 34877306 | 20,160,424 | 2021-11-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Mucosal inflammation'. | Metachronous squamous cell carcinoma of pancreas and stomach in an elderly female patient: A case report.
BACKGROUND
Squamous cell carcinoma (SCC) in pancreas and stomach is a rare histologic subtype with aggressive behavior, poor prognosis, and no standardized therapy. Pancreatic SCC or gastric SCC has been previously... | CAPECITABINE, OXALIPLATIN | DrugsGivenReaction | CC BY-NC | 34877306 | 20,160,424 | 2021-11-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapeutic product effect incomplete'. | Metachronous squamous cell carcinoma of pancreas and stomach in an elderly female patient: A case report.
BACKGROUND
Squamous cell carcinoma (SCC) in pancreas and stomach is a rare histologic subtype with aggressive behavior, poor prognosis, and no standardized therapy. Pancreatic SCC or gastric SCC has been previously... | CAPECITABINE, OXALIPLATIN | DrugsGivenReaction | CC BY-NC | 34877306 | 20,348,533 | 2021-11-06 |
What was the administration route of drug 'CAPECITABINE'? | Metachronous squamous cell carcinoma of pancreas and stomach in an elderly female patient: A case report.
BACKGROUND
Squamous cell carcinoma (SCC) in pancreas and stomach is a rare histologic subtype with aggressive behavior, poor prognosis, and no standardized therapy. Pancreatic SCC or gastric SCC has been previously... | Oral | DrugAdministrationRoute | CC BY-NC | 34877306 | 20,160,424 | 2021-11-06 |
What was the outcome of reaction 'Disease progression'? | Metachronous squamous cell carcinoma of pancreas and stomach in an elderly female patient: A case report.
BACKGROUND
Squamous cell carcinoma (SCC) in pancreas and stomach is a rare histologic subtype with aggressive behavior, poor prognosis, and no standardized therapy. Pancreatic SCC or gastric SCC has been previously... | Fatal | ReactionOutcome | CC BY-NC | 34877306 | 20,160,424 | 2021-11-06 |
What was the administration route of drug 'ASPIRIN'? | Clinical presentation and management of drug-induced gingival overgrowth: A case series.
BACKGROUND
We report three patients with drug-induced gingiva overgrowth (DIGO) caused by nifedipine, a calcium channel blocker, who were treated and followed up for 1-3 years. We discussed their symptoms, treatment process, treatm... | Oral | DrugAdministrationRoute | CC BY-NC | 34877332 | 20,188,628 | 2021-11-16 |
What was the administration route of drug 'CYCLOSPORINE'? | Clinical presentation and management of drug-induced gingival overgrowth: A case series.
BACKGROUND
We report three patients with drug-induced gingiva overgrowth (DIGO) caused by nifedipine, a calcium channel blocker, who were treated and followed up for 1-3 years. We discussed their symptoms, treatment process, treatm... | Oral | DrugAdministrationRoute | CC BY-NC | 34877332 | 20,188,628 | 2021-11-16 |
What was the administration route of drug 'NIFEDIPINE'? | Clinical presentation and management of drug-induced gingival overgrowth: A case series.
BACKGROUND
We report three patients with drug-induced gingiva overgrowth (DIGO) caused by nifedipine, a calcium channel blocker, who were treated and followed up for 1-3 years. We discussed their symptoms, treatment process, treatm... | Oral | DrugAdministrationRoute | CC BY-NC | 34877332 | 20,188,628 | 2021-11-16 |
What was the dosage of drug 'ASPIRIN'? | Clinical presentation and management of drug-induced gingival overgrowth: A case series.
BACKGROUND
We report three patients with drug-induced gingiva overgrowth (DIGO) caused by nifedipine, a calcium channel blocker, who were treated and followed up for 1-3 years. We discussed their symptoms, treatment process, treatm... | 81 mg (milligrams). | DrugDosage | CC BY-NC | 34877332 | 20,188,628 | 2021-11-16 |
What was the dosage of drug 'CYCLOSPORINE'? | Clinical presentation and management of drug-induced gingival overgrowth: A case series.
BACKGROUND
We report three patients with drug-induced gingiva overgrowth (DIGO) caused by nifedipine, a calcium channel blocker, who were treated and followed up for 1-3 years. We discussed their symptoms, treatment process, treatm... | 500 mg (milligrams). | DrugDosage | CC BY-NC | 34877332 | 20,188,628 | 2021-11-16 |
What was the outcome of reaction 'Gingival hypertrophy'? | Clinical presentation and management of drug-induced gingival overgrowth: A case series.
BACKGROUND
We report three patients with drug-induced gingiva overgrowth (DIGO) caused by nifedipine, a calcium channel blocker, who were treated and followed up for 1-3 years. We discussed their symptoms, treatment process, treatm... | Recovering | ReactionOutcome | CC BY-NC | 34877332 | 20,188,628 | 2021-11-16 |
What was the outcome of reaction 'Periodontitis'? | Clinical presentation and management of drug-induced gingival overgrowth: A case series.
BACKGROUND
We report three patients with drug-induced gingiva overgrowth (DIGO) caused by nifedipine, a calcium channel blocker, who were treated and followed up for 1-3 years. We discussed their symptoms, treatment process, treatm... | Recovering | ReactionOutcome | CC BY-NC | 34877332 | 20,188,628 | 2021-11-16 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease recurrence'. | Gastrointestinal symptoms as the first sign of chronic granulomatous disease in a neonate: A case report.
BACKGROUND
Chronic granulomatous disease (CGD) characterized by recurrent and severe bacterial and fungal infections is most common in childhood.
METHODS
We reported a 24-d-old male infant who developed gastroint... | LINEZOLID, SULFAMETHOXAZOLE\TRIMETHOPRIM, VORICONAZOLE | DrugsGivenReaction | CC BY-NC | 34877342 | 20,504,699 | 2021-11-16 |
What was the administration route of drug 'VORICONAZOLE'? | Gastrointestinal symptoms as the first sign of chronic granulomatous disease in a neonate: A case report.
BACKGROUND
Chronic granulomatous disease (CGD) characterized by recurrent and severe bacterial and fungal infections is most common in childhood.
METHODS
We reported a 24-d-old male infant who developed gastroint... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 34877342 | 20,504,699 | 2021-11-16 |
What was the dosage of drug 'VORICONAZOLE'? | Gastrointestinal symptoms as the first sign of chronic granulomatous disease in a neonate: A case report.
BACKGROUND
Chronic granulomatous disease (CGD) characterized by recurrent and severe bacterial and fungal infections is most common in childhood.
METHODS
We reported a 24-d-old male infant who developed gastroint... | 20 MILLIGRAM/KILOGRAM, DAILY | DrugDosageText | CC BY-NC | 34877342 | 20,504,699 | 2021-11-16 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Abdominal pain upper'. | Hepatic Artery Embolization for Palliation of Symptomatic Hypoglycemia in Patients With Hepatic Insulinoma Metastases.
Insulinoma is a pancreatic neuroendocrine tumor that causes hyperinsulinemic hypoglycemia. Symptomatic hypoglycemia related to hepatic insulinoma metastases may be addressed with liver-directed therapi... | BEVACIZUMAB | DrugsGivenReaction | CC BY-NC-ND | 34877442 | 20,428,249 | 2021-12-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Blood glucose fluctuation'. | Hepatic Artery Embolization for Palliation of Symptomatic Hypoglycemia in Patients With Hepatic Insulinoma Metastases.
Insulinoma is a pancreatic neuroendocrine tumor that causes hyperinsulinemic hypoglycemia. Symptomatic hypoglycemia related to hepatic insulinoma metastases may be addressed with liver-directed therapi... | BEVACIZUMAB | DrugsGivenReaction | CC BY-NC-ND | 34877442 | 20,428,249 | 2021-12-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Death'. | Hepatic Artery Embolization for Palliation of Symptomatic Hypoglycemia in Patients With Hepatic Insulinoma Metastases.
Insulinoma is a pancreatic neuroendocrine tumor that causes hyperinsulinemic hypoglycemia. Symptomatic hypoglycemia related to hepatic insulinoma metastases may be addressed with liver-directed therapi... | BEVACIZUMAB | DrugsGivenReaction | CC BY-NC-ND | 34877442 | 20,428,249 | 2021-12-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hepatic encephalopathy'. | Hepatic Artery Embolization for Palliation of Symptomatic Hypoglycemia in Patients With Hepatic Insulinoma Metastases.
Insulinoma is a pancreatic neuroendocrine tumor that causes hyperinsulinemic hypoglycemia. Symptomatic hypoglycemia related to hepatic insulinoma metastases may be addressed with liver-directed therapi... | BEVACIZUMAB | DrugsGivenReaction | CC BY-NC-ND | 34877442 | 20,428,249 | 2021-12-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypokalaemia'. | Hepatic Artery Embolization for Palliation of Symptomatic Hypoglycemia in Patients With Hepatic Insulinoma Metastases.
Insulinoma is a pancreatic neuroendocrine tumor that causes hyperinsulinemic hypoglycemia. Symptomatic hypoglycemia related to hepatic insulinoma metastases may be addressed with liver-directed therapi... | BEVACIZUMAB | DrugsGivenReaction | CC BY-NC-ND | 34877442 | 20,428,249 | 2021-12-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Nausea'. | Hepatic Artery Embolization for Palliation of Symptomatic Hypoglycemia in Patients With Hepatic Insulinoma Metastases.
Insulinoma is a pancreatic neuroendocrine tumor that causes hyperinsulinemic hypoglycemia. Symptomatic hypoglycemia related to hepatic insulinoma metastases may be addressed with liver-directed therapi... | BEVACIZUMAB | DrugsGivenReaction | CC BY-NC-ND | 34877442 | 20,428,249 | 2021-12-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Hepatic Artery Embolization for Palliation of Symptomatic Hypoglycemia in Patients With Hepatic Insulinoma Metastases.
Insulinoma is a pancreatic neuroendocrine tumor that causes hyperinsulinemic hypoglycemia. Symptomatic hypoglycemia related to hepatic insulinoma metastases may be addressed with liver-directed therapi... | BEVACIZUMAB | DrugsGivenReaction | CC BY-NC-ND | 34877442 | 20,428,249 | 2021-12-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pain'. | Hepatic Artery Embolization for Palliation of Symptomatic Hypoglycemia in Patients With Hepatic Insulinoma Metastases.
Insulinoma is a pancreatic neuroendocrine tumor that causes hyperinsulinemic hypoglycemia. Symptomatic hypoglycemia related to hepatic insulinoma metastases may be addressed with liver-directed therapi... | BEVACIZUMAB | DrugsGivenReaction | CC BY-NC-ND | 34877442 | 20,428,249 | 2021-12-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use in unapproved indication'. | Hepatic Artery Embolization for Palliation of Symptomatic Hypoglycemia in Patients With Hepatic Insulinoma Metastases.
Insulinoma is a pancreatic neuroendocrine tumor that causes hyperinsulinemic hypoglycemia. Symptomatic hypoglycemia related to hepatic insulinoma metastases may be addressed with liver-directed therapi... | CAPECITABINE, DIAZOXIDE, SOMATOSTATIN, TEMOZOLOMIDE | DrugsGivenReaction | CC BY-NC-ND | 34877442 | 20,486,524 | 2021-12-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pyrexia'. | Hepatic Artery Embolization for Palliation of Symptomatic Hypoglycemia in Patients With Hepatic Insulinoma Metastases.
Insulinoma is a pancreatic neuroendocrine tumor that causes hyperinsulinemic hypoglycemia. Symptomatic hypoglycemia related to hepatic insulinoma metastases may be addressed with liver-directed therapi... | BEVACIZUMAB | DrugsGivenReaction | CC BY-NC-ND | 34877442 | 20,428,249 | 2021-12-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Vomiting'. | Hepatic Artery Embolization for Palliation of Symptomatic Hypoglycemia in Patients With Hepatic Insulinoma Metastases.
Insulinoma is a pancreatic neuroendocrine tumor that causes hyperinsulinemic hypoglycemia. Symptomatic hypoglycemia related to hepatic insulinoma metastases may be addressed with liver-directed therapi... | BEVACIZUMAB | DrugsGivenReaction | CC BY-NC-ND | 34877442 | 20,428,249 | 2021-12-01 |
What was the outcome of reaction 'Death'? | Hepatic Artery Embolization for Palliation of Symptomatic Hypoglycemia in Patients With Hepatic Insulinoma Metastases.
Insulinoma is a pancreatic neuroendocrine tumor that causes hyperinsulinemic hypoglycemia. Symptomatic hypoglycemia related to hepatic insulinoma metastases may be addressed with liver-directed therapi... | Fatal | ReactionOutcome | CC BY-NC-ND | 34877442 | 20,428,249 | 2021-12-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Labelled drug-drug interaction medication error'. | Safety and Efficacy of Percutaneous Image-Guided Mediastinal Mass Core-Needle Biopsy.
To retrospectively evaluate the safety and efficacy of percutaneous image-guided mediastinal mass core-needle biopsy.
Retrospective review of an institutionally maintained biopsy registry identified 337 computed tomography- or ultraso... | ASPIRIN, WARFARIN | DrugsGivenReaction | CC BY-NC-ND | 34877475 | 20,647,621 | 2021-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pericardial haemorrhage'. | Safety and Efficacy of Percutaneous Image-Guided Mediastinal Mass Core-Needle Biopsy.
To retrospectively evaluate the safety and efficacy of percutaneous image-guided mediastinal mass core-needle biopsy.
Retrospective review of an institutionally maintained biopsy registry identified 337 computed tomography- or ultraso... | ASPIRIN, WARFARIN | DrugsGivenReaction | CC BY-NC-ND | 34877475 | 20,647,621 | 2021-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Nephrolithiasis'. | Atypical presentation of SLC30A10 gene mutation with hypermanganesemia, seizures and polycythemia.
Manganese is an essential element that is ubiquitously present in our diet and water supply. It is a cofactor for several critical physiological processes. Elevated blood levels of Manganese secondary to SLC30A10 gene mut... | FERROUS SULFATE, LAMOTRIGINE, LEVETIRACETAM, SUCCIMER, TOPIRAMATE, VALPROIC ACID | DrugsGivenReaction | CC BY-NC-ND | 34877518 | 20,470,433 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Atypical presentation of SLC30A10 gene mutation with hypermanganesemia, seizures and polycythemia.
Manganese is an essential element that is ubiquitously present in our diet and water supply. It is a cofactor for several critical physiological processes. Elevated blood levels of Manganese secondary to SLC30A10 gene mut... | FERROUS SULFATE, LAMOTRIGINE, LEVETIRACETAM, SUCCIMER, TOPIRAMATE, VALPROIC ACID | DrugsGivenReaction | CC BY-NC-ND | 34877518 | 20,470,433 | 2021 |
What was the administration route of drug 'SUCCIMER'? | Atypical presentation of SLC30A10 gene mutation with hypermanganesemia, seizures and polycythemia.
Manganese is an essential element that is ubiquitously present in our diet and water supply. It is a cofactor for several critical physiological processes. Elevated blood levels of Manganese secondary to SLC30A10 gene mut... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 34877518 | 20,470,433 | 2021 |
What was the dosage of drug 'FERROUS SULFATE'? | Atypical presentation of SLC30A10 gene mutation with hypermanganesemia, seizures and polycythemia.
Manganese is an essential element that is ubiquitously present in our diet and water supply. It is a cofactor for several critical physiological processes. Elevated blood levels of Manganese secondary to SLC30A10 gene mut... | UNK, FOR 5 DAYS EVERY 4 WEEKS | DrugDosageText | CC BY-NC-ND | 34877518 | 20,470,433 | 2021 |
What was the dosage of drug 'LAMOTRIGINE'? | Atypical presentation of SLC30A10 gene mutation with hypermanganesemia, seizures and polycythemia.
Manganese is an essential element that is ubiquitously present in our diet and water supply. It is a cofactor for several critical physiological processes. Elevated blood levels of Manganese secondary to SLC30A10 gene mut... | UNK UNK, UNK | DrugDosageText | CC BY-NC-ND | 34877518 | 20,470,433 | 2021 |
What was the dosage of drug 'LEVETIRACETAM'? | Atypical presentation of SLC30A10 gene mutation with hypermanganesemia, seizures and polycythemia.
Manganese is an essential element that is ubiquitously present in our diet and water supply. It is a cofactor for several critical physiological processes. Elevated blood levels of Manganese secondary to SLC30A10 gene mut... | UNK UNK, UNK | DrugDosageText | CC BY-NC-ND | 34877518 | 20,470,433 | 2021 |
What was the dosage of drug 'SUCCIMER'? | Atypical presentation of SLC30A10 gene mutation with hypermanganesemia, seizures and polycythemia.
Manganese is an essential element that is ubiquitously present in our diet and water supply. It is a cofactor for several critical physiological processes. Elevated blood levels of Manganese secondary to SLC30A10 gene mut... | UNK UNK, UNK | DrugDosageText | CC BY-NC-ND | 34877518 | 20,470,433 | 2021 |
What was the dosage of drug 'TOPIRAMATE'? | Atypical presentation of SLC30A10 gene mutation with hypermanganesemia, seizures and polycythemia.
Manganese is an essential element that is ubiquitously present in our diet and water supply. It is a cofactor for several critical physiological processes. Elevated blood levels of Manganese secondary to SLC30A10 gene mut... | UNK UNK, UNK | DrugDosageText | CC BY-NC-ND | 34877518 | 20,470,433 | 2021 |
What was the dosage of drug 'VALPROIC ACID'? | Atypical presentation of SLC30A10 gene mutation with hypermanganesemia, seizures and polycythemia.
Manganese is an essential element that is ubiquitously present in our diet and water supply. It is a cofactor for several critical physiological processes. Elevated blood levels of Manganese secondary to SLC30A10 gene mut... | UNK UNK, UNK | DrugDosageText | CC BY-NC-ND | 34877518 | 20,470,433 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Implementation of a clinical decision rule for selecting empiric treatment for invasive aspergillosis in a setting with high triazole resistance.
World-wide, emerging triazole resistance increasingly complicates treatment of invasive aspergillosis (IA). In settings with substantial (>10%) prevalence of triazole resista... | VORICONAZOLE | DrugsGivenReaction | CC BY-NC | 34878121 | 20,374,528 | 2021-12-08 |
What was the outcome of reaction 'Drug ineffective'? | Implementation of a clinical decision rule for selecting empiric treatment for invasive aspergillosis in a setting with high triazole resistance.
World-wide, emerging triazole resistance increasingly complicates treatment of invasive aspergillosis (IA). In settings with substantial (>10%) prevalence of triazole resista... | Fatal | ReactionOutcome | CC BY-NC | 34878121 | 20,374,528 | 2021-12-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pneumonia'. | Pembrolizumab versus paclitaxel for previously treated advanced gastric or gastroesophageal junction cancer (KEYNOTE-063): A randomized, open-label, phase 3 trial in Asian patients.
BACKGROUND
KEYNOTE-063 (NCT03019588) investigated pembrolizumab versus paclitaxel as second-line therapy in Asian patients with advanced p... | PACLITAXEL | DrugsGivenReaction | CC BY-NC | 34878659 | 20,214,020 | 2021-12-08 |
What was the administration route of drug 'PACLITAXEL'? | Pembrolizumab versus paclitaxel for previously treated advanced gastric or gastroesophageal junction cancer (KEYNOTE-063): A randomized, open-label, phase 3 trial in Asian patients.
BACKGROUND
KEYNOTE-063 (NCT03019588) investigated pembrolizumab versus paclitaxel as second-line therapy in Asian patients with advanced p... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 34878659 | 20,214,020 | 2021-12-08 |
What was the outcome of reaction 'Pneumonia'? | Pembrolizumab versus paclitaxel for previously treated advanced gastric or gastroesophageal junction cancer (KEYNOTE-063): A randomized, open-label, phase 3 trial in Asian patients.
BACKGROUND
KEYNOTE-063 (NCT03019588) investigated pembrolizumab versus paclitaxel as second-line therapy in Asian patients with advanced p... | Fatal | ReactionOutcome | CC BY-NC | 34878659 | 20,214,020 | 2021-12-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'COVID-19'. | Convalescent plasma treatment in severely immunosuppressed patients hospitalized with COVID-19: an observational study of 28 cases.
Immunosuppressed patients are particularly vulnerable to severe infection from the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), risking prolonged viremia and symptom durat... | ENOXAPARIN SODIUM, REMDESIVIR, RITUXIMAB | DrugsGivenReaction | CC BY-NC-ND | 34878955 | 20,367,747 | 2021-12-08 |
What was the outcome of reaction 'COVID-19'? | Convalescent plasma treatment in severely immunosuppressed patients hospitalized with COVID-19: an observational study of 28 cases.
Immunosuppressed patients are particularly vulnerable to severe infection from the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), risking prolonged viremia and symptom durat... | Fatal | ReactionOutcome | CC BY-NC-ND | 34878955 | 20,367,747 | 2021-12-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cardiomyopathy'. | A Case Series of Adult Patients Diagnosed with IgA Vasculitis Requiring Systemic Immunosuppression.
BACKGROUND IgA vasculitis (IgAV) is a rare and potentially life-threatening small-vessel vasculitis in adults. The disease course is often more severe than its childhood counterpart. The disease is noted for its heteroge... | VALGANCICLOVIR | DrugsGivenReaction | CC BY-NC-ND | 34879054 | 20,262,734 | 2021-12-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Condition aggravated'. | A Case Series of Adult Patients Diagnosed with IgA Vasculitis Requiring Systemic Immunosuppression.
BACKGROUND IgA vasculitis (IgAV) is a rare and potentially life-threatening small-vessel vasculitis in adults. The disease course is often more severe than its childhood counterpart. The disease is noted for its heteroge... | AZATHIOPRINE, METHYLPREDNISOLONE, MYCOPHENOLATE MOFETIL, PREDNISOLONE, RITUXIMAB, SIROLIMUS, VALGANCICLOVIR | DrugsGivenReaction | CC BY-NC-ND | 34879054 | 20,263,702 | 2021-12-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective for unapproved indication'. | A Case Series of Adult Patients Diagnosed with IgA Vasculitis Requiring Systemic Immunosuppression.
BACKGROUND IgA vasculitis (IgAV) is a rare and potentially life-threatening small-vessel vasculitis in adults. The disease course is often more severe than its childhood counterpart. The disease is noted for its heteroge... | AZATHIOPRINE, METHYLPREDNISOLONE, MYCOPHENOLIC ACID, PREDNISOLONE, RITUXIMAB, SIROLIMUS | DrugsGivenReaction | CC BY-NC-ND | 34879054 | 20,308,652 | 2021-12-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | A Case Series of Adult Patients Diagnosed with IgA Vasculitis Requiring Systemic Immunosuppression.
BACKGROUND IgA vasculitis (IgAV) is a rare and potentially life-threatening small-vessel vasculitis in adults. The disease course is often more severe than its childhood counterpart. The disease is noted for its heteroge... | AZATHIOPRINE, METHYLPREDNISOLONE, MYCOPHENOLATE MOFETIL, PREDNISOLONE, RITUXIMAB, SIROLIMUS | DrugsGivenReaction | CC BY-NC-ND | 34879054 | 20,280,287 | 2021-12-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Neutropenia'. | A Case Series of Adult Patients Diagnosed with IgA Vasculitis Requiring Systemic Immunosuppression.
BACKGROUND IgA vasculitis (IgAV) is a rare and potentially life-threatening small-vessel vasculitis in adults. The disease course is often more severe than its childhood counterpart. The disease is noted for its heteroge... | VALGANCICLOVIR | DrugsGivenReaction | CC BY-NC-ND | 34879054 | 20,262,734 | 2021-12-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapy partial responder'. | A Case Series of Adult Patients Diagnosed with IgA Vasculitis Requiring Systemic Immunosuppression.
BACKGROUND IgA vasculitis (IgAV) is a rare and potentially life-threatening small-vessel vasculitis in adults. The disease course is often more severe than its childhood counterpart. The disease is noted for its heteroge... | AZATHIOPRINE, METHYLPREDNISOLONE, MYCOPHENOLATE MOFETIL, PREDNISOLONE, RITUXIMAB, SIROLIMUS, VALGANCICLOVIR | DrugsGivenReaction | CC BY-NC-ND | 34879054 | 20,263,702 | 2021-12-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Treatment failure'. | A Case Series of Adult Patients Diagnosed with IgA Vasculitis Requiring Systemic Immunosuppression.
BACKGROUND IgA vasculitis (IgAV) is a rare and potentially life-threatening small-vessel vasculitis in adults. The disease course is often more severe than its childhood counterpart. The disease is noted for its heteroge... | AZATHIOPRINE, MYCOPHENOLATE MOFETIL, PREDNISOLONE, SIROLIMUS | DrugsGivenReaction | CC BY-NC-ND | 34879054 | 20,307,458 | 2021-12-08 |
What was the administration route of drug 'AZATHIOPRINE'? | A Case Series of Adult Patients Diagnosed with IgA Vasculitis Requiring Systemic Immunosuppression.
BACKGROUND IgA vasculitis (IgAV) is a rare and potentially life-threatening small-vessel vasculitis in adults. The disease course is often more severe than its childhood counterpart. The disease is noted for its heteroge... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 34879054 | 20,280,287 | 2021-12-08 |
What was the administration route of drug 'METHYLPREDNISOLONE SODIUM SUCCINATE'? | A Case Series of Adult Patients Diagnosed with IgA Vasculitis Requiring Systemic Immunosuppression.
BACKGROUND IgA vasculitis (IgAV) is a rare and potentially life-threatening small-vessel vasculitis in adults. The disease course is often more severe than its childhood counterpart. The disease is noted for its heteroge... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 34879054 | 20,227,707 | 2021-12-08 |
What was the administration route of drug 'MYCOPHENOLATE MOFETIL'? | A Case Series of Adult Patients Diagnosed with IgA Vasculitis Requiring Systemic Immunosuppression.
BACKGROUND IgA vasculitis (IgAV) is a rare and potentially life-threatening small-vessel vasculitis in adults. The disease course is often more severe than its childhood counterpart. The disease is noted for its heteroge... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 34879054 | 20,280,287 | 2021-12-08 |
What was the administration route of drug 'MYCOPHENOLIC ACID'? | A Case Series of Adult Patients Diagnosed with IgA Vasculitis Requiring Systemic Immunosuppression.
BACKGROUND IgA vasculitis (IgAV) is a rare and potentially life-threatening small-vessel vasculitis in adults. The disease course is often more severe than its childhood counterpart. The disease is noted for its heteroge... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 34879054 | 20,308,652 | 2021-12-08 |
What was the administration route of drug 'PREDNISOLONE'? | A Case Series of Adult Patients Diagnosed with IgA Vasculitis Requiring Systemic Immunosuppression.
BACKGROUND IgA vasculitis (IgAV) is a rare and potentially life-threatening small-vessel vasculitis in adults. The disease course is often more severe than its childhood counterpart. The disease is noted for its heteroge... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 34879054 | 20,227,707 | 2021-12-08 |
What was the administration route of drug 'RITUXIMAB'? | A Case Series of Adult Patients Diagnosed with IgA Vasculitis Requiring Systemic Immunosuppression.
BACKGROUND IgA vasculitis (IgAV) is a rare and potentially life-threatening small-vessel vasculitis in adults. The disease course is often more severe than its childhood counterpart. The disease is noted for its heteroge... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 34879054 | 20,227,707 | 2021-12-08 |
What was the administration route of drug 'SIROLIMUS'? | A Case Series of Adult Patients Diagnosed with IgA Vasculitis Requiring Systemic Immunosuppression.
BACKGROUND IgA vasculitis (IgAV) is a rare and potentially life-threatening small-vessel vasculitis in adults. The disease course is often more severe than its childhood counterpart. The disease is noted for its heteroge... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 34879054 | 20,280,287 | 2021-12-08 |
What was the outcome of reaction 'Cardiomyopathy'? | A Case Series of Adult Patients Diagnosed with IgA Vasculitis Requiring Systemic Immunosuppression.
BACKGROUND IgA vasculitis (IgAV) is a rare and potentially life-threatening small-vessel vasculitis in adults. The disease course is often more severe than its childhood counterpart. The disease is noted for its heteroge... | Fatal | ReactionOutcome | CC BY-NC-ND | 34879054 | 20,262,734 | 2021-12-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Treatment of adult Burkitt lymphoma with the CALGB 1002 protocol: a single center experience in Jordan.
The treatment of adult Burkitt lymphoma with pediatric-based chemotherapy protocols usually results in high cure rates, although with significant toxicity. We report our experience with the Cancer and Leukemia Group ... | CYCLOPHOSPHAMIDE, CYTARABINE, DEXAMETHASONE, DOXORUBICIN, ETOPOSIDE, FILGRASTIM, HYDROCORTISONE, IFOSFAMIDE, LEUCOVORIN, MESNA, METHOTREXATE, PREDNISOLONE, RITUXIMAB, VINCRISTINE | DrugsGivenReaction | CC BY-NC | 34880141 | 20,994,380 | 2021-12-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Sepsis'. | Treatment of adult Burkitt lymphoma with the CALGB 1002 protocol: a single center experience in Jordan.
The treatment of adult Burkitt lymphoma with pediatric-based chemotherapy protocols usually results in high cure rates, although with significant toxicity. We report our experience with the Cancer and Leukemia Group ... | CYCLOPHOSPHAMIDE, CYTARABINE, DEXAMETHASONE, DOXORUBICIN, ETOPOSIDE, FILGRASTIM, HYDROCORTISONE, IFOSFAMIDE, LEUCOVORIN, MESNA, METHOTREXATE, PREDNISOLONE, RITUXIMAB, VINCRISTINE | DrugsGivenReaction | CC BY-NC | 34880141 | 20,994,380 | 2021-12-09 |
What was the administration route of drug 'CYTARABINE'? | Treatment of adult Burkitt lymphoma with the CALGB 1002 protocol: a single center experience in Jordan.
The treatment of adult Burkitt lymphoma with pediatric-based chemotherapy protocols usually results in high cure rates, although with significant toxicity. We report our experience with the Cancer and Leukemia Group ... | Intrathecal | DrugAdministrationRoute | CC BY-NC | 34880141 | 20,994,380 | 2021-12-09 |
What was the administration route of drug 'HYDROCORTISONE'? | Treatment of adult Burkitt lymphoma with the CALGB 1002 protocol: a single center experience in Jordan.
The treatment of adult Burkitt lymphoma with pediatric-based chemotherapy protocols usually results in high cure rates, although with significant toxicity. We report our experience with the Cancer and Leukemia Group ... | Intrathecal | DrugAdministrationRoute | CC BY-NC | 34880141 | 20,994,380 | 2021-12-09 |
What was the administration route of drug 'METHOTREXATE'? | Treatment of adult Burkitt lymphoma with the CALGB 1002 protocol: a single center experience in Jordan.
The treatment of adult Burkitt lymphoma with pediatric-based chemotherapy protocols usually results in high cure rates, although with significant toxicity. We report our experience with the Cancer and Leukemia Group ... | Intrathecal | DrugAdministrationRoute | CC BY-NC | 34880141 | 20,994,380 | 2021-12-09 |
What was the dosage of drug 'DEXAMETHASONE'? | Treatment of adult Burkitt lymphoma with the CALGB 1002 protocol: a single center experience in Jordan.
The treatment of adult Burkitt lymphoma with pediatric-based chemotherapy protocols usually results in high cure rates, although with significant toxicity. We report our experience with the Cancer and Leukemia Group ... | 10 MILLIGRAM/SQ. METER, CYCLICAL (CYCLE 3, 5, AND 7. ON DAYS 4-5) | DrugDosageText | CC BY-NC | 34880141 | 20,994,380 | 2021-12-09 |
What was the dosage of drug 'DOXORUBICIN'? | Treatment of adult Burkitt lymphoma with the CALGB 1002 protocol: a single center experience in Jordan.
The treatment of adult Burkitt lymphoma with pediatric-based chemotherapy protocols usually results in high cure rates, although with significant toxicity. We report our experience with the Cancer and Leukemia Group ... | 25 MILLIGRAM/SQ. METER, CYCLICAL (CYCLE 3, 5, AND 7. ON DAYS 4-5) | DrugDosageText | CC BY-NC | 34880141 | 20,994,380 | 2021-12-09 |
What was the dosage of drug 'ETOPOSIDE'? | Treatment of adult Burkitt lymphoma with the CALGB 1002 protocol: a single center experience in Jordan.
The treatment of adult Burkitt lymphoma with pediatric-based chemotherapy protocols usually results in high cure rates, although with significant toxicity. We report our experience with the Cancer and Leukemia Group ... | 80 MILLIGRAM/SQ. METER, CYCLICAL (CYCLE 2,4,6: ON DAYS 4-5) | DrugDosageText | CC BY-NC | 34880141 | 20,994,380 | 2021-12-09 |
What was the dosage of drug 'IFOSFAMIDE'? | Treatment of adult Burkitt lymphoma with the CALGB 1002 protocol: a single center experience in Jordan.
The treatment of adult Burkitt lymphoma with pediatric-based chemotherapy protocols usually results in high cure rates, although with significant toxicity. We report our experience with the Cancer and Leukemia Group ... | 800 MILLIGRAM/SQ. METER, CYCLICAL (CYCLE 2,4,6: ON DAYS 1-5) | DrugDosageText | CC BY-NC | 34880141 | 20,994,380 | 2021-12-09 |
What was the dosage of drug 'MESNA'? | Treatment of adult Burkitt lymphoma with the CALGB 1002 protocol: a single center experience in Jordan.
The treatment of adult Burkitt lymphoma with pediatric-based chemotherapy protocols usually results in high cure rates, although with significant toxicity. We report our experience with the Cancer and Leukemia Group ... | 200 MILLIGRAM/SQ. METER, CYCLICAL (CYCLE 2,4,6: ON DAYS 1-5, AT HOURS 0, 4, AND 8 AFTER IFOSFAMIDE) | DrugDosageText | CC BY-NC | 34880141 | 20,994,380 | 2021-12-09 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.